Phunware, Inc. PHUN 深 滬
等待開盤 08-19 09:30:00 美东时间
2.74
+0.070
+2.62%
華盛通- 最 高2.76
- 今 開2.65
- 成交量 19.56万股
- 最 低 2.65
- 昨 收 2.67
- 總市值 3106.94万
- 52周最高 14.60
- 市盈率 靜 --
- 換手率 1.72%
- 52周最低 2.22
- 委 比 -36.07%
- 總股本 1133.92万
- 歷史最高 27500.00
- 量 比 0.73
- 振 幅 4.12%
- 歷史最低 2.22
- 每 手 1
- 風險率 3.83%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多HC Wainwright & Co. Reiterates Neutral on Phunware, Maintains $3 Price Target
HC Wainwright & Co. analyst Scott Buck reiterates Phunware (NASDAQ:PHUN) with a Neutral and maintains $3 price target.
08-14 19:07
Phunware Q2 EPS $(0.16) Misses $(0.15) Estimate, Sales $455.000K Miss $726.500K Estimate
Phunware (NASDAQ:PHUN) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.15) by 6.67 percent. This is a 50 percent increase over losses of $(0.32) per share from the same
08-09 04:07
Phunware names Jeremy Krol as interim CEO
Phunware (NASDAQ:PHUN) said on Monday that its board has appointed Jeremy Krol, the company’s current Chief Operating Officer, as its new interim CEO, replacing Stephen Chen. Krol has served as the c...
07-14 20:45
Phunware Appoints Rahul Mewawalla As Executive Chairman And Chief AI Architect
In addition, the Company has appointed Mr. Rahul Mewawalla, a member of the Company's Board of Directors, as the Company's Executive Chairman and Chief Artificial Intelligence (AI) Architect. In this dual role, Mr.
07-14 20:12
Phunware Announces Updates to Senior Leadership Team
Austin, Texas, July 14, 2025 – Phunware, Inc. announced leadership updates: Jeremy Krol appointed as Interim CEO and Rahul Mewawalla as Executive Chairman and Chief AI Architect. Krol, with a background in optimizing operations and leading transitions, replaces Stephen Chen. Mewawalla, bringing extensive AI and technology expertise, will focus on strategic initiatives and advancing AI priorities. The Company expressed confidence in their leadersh...
07-14 12:00
美股大行评级 | 潜在涨幅925.64%！Aemetis获Ascendiant Capital升目标价至20美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1138028221594226688.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Ascendiant Capital：维持Aemetis(AMTX)"买入"评级，目标价从19美元升至20美元</p> <p>• Ascendiant Capital：维持Lucid Diagnostics(LUCD)"买
06-07 08:37
Ascendiant Capital Maintains Buy on Phunware, Raises Price Target to $12.5
Ascendiant Capital analyst Edward Woo maintains Phunware (NASDAQ:PHUN) with a Buy and raises the price target from $12 to $12.5.
06-06 18:49
Phunware Q1 EPS $(0.18) Misses $(0.12) Estimate, Sales $688.00K Beat $674.75K Estimate
Phunware (NASDAQ:PHUN) reported quarterly losses of $(0.18) per share which missed the analyst consensus estimate of $(0.12) by 50 percent. This is a 45.45 percent increase over losses of $(0.33) per share from the same
05-13 04:47
美股大行评级 | 潜在涨幅3020.12%！Ascendiant Capital上调Plus Therapeutics目标价至20美元，维持"买入"评级
每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。
04-22 08:41
美股大行评级 | 潜在涨幅586.27%！HC Wainwright & Co.上调Enlivex Therapeutics目标价至7美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1111211417521721345.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持Enlivex Therapeutics(ENLV)"买入"评级，目标价从6美元升至7美元</p> <p>• Maxim Group：上调Nexalin Technolo
03-25 09:37
